Back To: Home



January 19-23, 2015
PepTalk - San Diego, CA

February 7-11, 2015
SLAS2015 - Washington, DC

More Events
Name:
Company:
Email:
 
 
 

New bill to speed approval for breakthrough drugs
May 2012
SHARING OPTIONS:

WASHINGTON, D.C.—A new bipartisan bill has been proposed that would require the U.S. Food and Drug Administration (FDA) to speed up the development and review of breakthrough drugs. With the Advancing Breakthrough Therapies for Patients Act—introduced by Sen. Michael Bennet, D-Colo.; Sen. Orrin Hatch, R-Utah; and Sen. Richard Burr, R-N.C.—if a company believes its drug qualifies, it can request a breakthrough designation, after which the FDA has 60 days to determine the accuracy of the claim. Following designation, the FDA would then meet with the sponsor throughout the drug's development, minimizing the number of patients required in clinical trials and shortening the trials' duration, among other things. The bill also has backing from Friends of Cancer Research and the National Venture Capital Association.   



Back








CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2014 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.